Obstructive sleep apnea: A diagnostic and treatment guide

Journal of Family Practice

Volumn 62, Issue 10, 2013, Pages 565-572

  Gutierrez, Cecilia ^a   Brady, Patricia ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ATORVASTATIN; ESZOPICLONE; FLUOXETINE; FLUTICASONE; GLIBENCLAMIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HYDROCHLOROTHIAZIDE; LISINOPRIL; METFORMIN; NALTREXONE; ONDANSETRON; PAROXETINE;

ADULT; ALCOHOL ABSTINENCE; ANXIETY; APNEA HYPOPNEA INDEX; ARTICLE; BODY MASS; CALORIC INTAKE; CASE REPORT; CHOLINERGIC ACTIVITY; CPAP DEVICE; DAYTIME SOMNOLENCE; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; ELECTROENCEPHALOGRAM; EPWORTH SLEEPINESS SCALE; FATIGUE; FEMALE; GLUCOSE BLOOD LEVEL; HEADACHE; HEART ARRHYTHMIA; HEMOGLOBIN BLOOD LEVEL; HOME MONITORING; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIFESTYLE MODIFICATION; MALE; MEDICAL HISTORY; METABOLIC SYNDROME X; NARCOLEPSY; NOSE OBSTRUCTION; OBESITY; OXYGEN DESATURATION; PARASOMNIA; PATIENT COMPLIANCE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; REM SLEEP; RESPIRATORY THERAPEUTIC DEVICE; RESTLESS LEGS SYNDROME; RETROGNATHIA; SLEEP DISORDERED BREATHING; SNORING; TONGUE RETAINING DEVICE; UVULOPALATOPHARYNGOPLASTY; WEIGHT REDUCTION;

ADULT; ALCOHOL DRINKING; BODY MASS INDEX; CONTINUOUS POSITIVE AIRWAY PRESSURE; DIABETES COMPLICATIONS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; POLYSOMNOGRAPHY; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84885156795     PISSN: 00943509     EISSN: 15337294     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Dempsey JA, Veasey SC, Morgan BJ, et al. Pathophysiology of sleep apnea. Physiol Rev. 2010;90:47-112.
2. Jenkinson C, Stradling J, Petersen S. Comparison of three measures of quality of life outcome in the evaluation of continuous positive airways pressure therapy for sleep apnoea. J Sleep Res. 1997;6:199-204. (Pubitemid 27414460)
3. Satela MJ. Neuropsychological impairment and quality of life in obstructive sleep apnea. Clin Chest Med. 2003;24:249-259.
4. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165:1217-1239. (Pubitemid 34461732)
5. Yaggi HK, Concato J, Kernan W, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034-2041. (Pubitemid 41609096)
6. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046-1053. (Pubitemid 40386782)
7. Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep. 2008;3:1071-1078.
8. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008;5:136-143. (Pubitemid 351237871)
9. Coughlin SR, Mawdsley L, Mugarza JA, et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25:735-741. (Pubitemid 38647933)
10. Basta M, Vgontzas AN. Metabolic abnormalities in obesity and sleep apnea are in a continuum. Sleep Med. 2007;8:5-7. (Pubitemid 46044138)
11. Peppard PE, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000;284:3015-3021. (Pubitemid 32014738)
12. Parish JM, Adam T, Facchiano L. Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med. 2007;3:467-472. (Pubitemid 47378249)
13. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA. 2004;291:2013-2016. (Pubitemid 38544284)
14. Skomro RP, Gjevre J, Reid J, et al. Outcomes of home-base diagnosis and treatment of obstructive sleep apnea. Chest. 2010;138:257-263.
15. Iber C, Ancoli-Israel S, Chesson AL Jr, et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Westchester, IL: American Academy of Sleep Medicine; 2007.
16. Johns MW. Sensitivity and specificity of the multiple sleep maintenance tests, the maintenance of wakefulness tests and the Epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res. 2000;9:5-11. (Pubitemid 30195287)
17. Hesselbacher S, Subramanian S, Allen J, et al. Body mass index, gender, and ethnic variations alter the clinical implication of the Epworth sleepiness scale in patients with suspected of obstructive sleep apnea. Open Respir Med J. 2012;6:2020-2027.
18. Ahmadi N, Chung S, Gibbs A, et al. The Berlin questionnaire for sleep apnea in a sleep clinic population: relationship to polysomnographic measurement of respiratory disturbance. Sleep Breath. 2008;12:38-45.
19. Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008;108:812-821. (Pubitemid 351589476)
20. Shneerson J, Wright J. Lifestyle modification for obstructive sleep apnoea. Cochrane Database Syst Rev. 2001;(1):CD002875.
21. Barvaux VA, Aubert G, Rodenstein DO. Weight loss as treatment for obstructive sleep apnea. Sleep Med Rev. 2000;4:435-452.
22. Buchwald H, Avidor H, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-1737. (Pubitemid 39346675)
23. Dixon JB, Schachter LM, O'Brien PE, et al. Surgical vs. conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;308:1142-1149.
24. Greenburg A, Lettieri C, Arn E. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med. 2009;122:535-542.
25. Sagawa Y, Kondo H, Matsubuchi N. Alcohol has a dose-related effect on parasympathetic nerve activity during sleep. Alcohol Clin Exp Res. 2011;35:2093-2100.
26. Vakulin A, Baulk SD, Catcheside PG, et al. Effects of alcohol and sleep restriction on simulated driving performance in untreated patients with obstructive sleep apnea. Ann Intern Med. 2009;151:447-455.
27. Patel SR, White DP, Malhotra A, et al. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med. 2003;163:565-571. (Pubitemid 36314343)
28. Giles TL, Lasserson TJ, Smith BH, et al. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2006;(3):CD001106.
29. Simantirakis EN, Schiza SI, Marketou ME, et al. Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: a long-term evaluation using an insertable loop recorder. Eur Heart J. 2004;25:1070-1076. (Pubitemid 38869427)
30. Marshall NS, Barnes M, Travier N, et al. Continuous positive airway pressure reduces daytime sleepiness in mild to moderate obstructive sleep apnoea: a meta-analysis. Thorax. 2006;61:430-434. (Pubitemid 43723328)
31. Findley L, Smith C, Hooper J, et al. Treatment with nasal CPAP decreases automobile accidents in patient with sleep apnea. Am J Respir Crit Care Med. 2000;161:857-859. (Pubitemid 30171742)
32. Barbe F, Sunyer J, de la Pena A, et al. Effects of continuous positive airway pressure on the risk of road accidents in sleep apnea patients. Respiration. 2007;74:44-49. (Pubitemid 46012446)
33. Sin DD, Mayers I, Man GC, et al. Long Term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population based study. Chest. 2002;121:430-435. (Pubitemid 34132979)
34. Cormican LJ, Williams A. Sleep disordered breathing and its treatment in congestive heart failure. Heart. 2005;91:1265-1270. (Pubitemid 41360933)
35. Lindberg E, Berne C, Elmasry A, et al. CPAP treatment of a population-based sample - what are the benefits and the treatment compliance? Sleep Med. 2006;7:553-560. (Pubitemid 44480744)
36. Engleman HM, Wild MR. Improving CPAP use by patients with the sleep apnea-hypopnea syndrome (SAHS). Sleep Med. 2003;7:81-99. (Pubitemid 36188308)
37. Blau A, Minx M, Peter JG, et al. Auto bi-level pressure relief-PAP is as effective as CPAP in OSA patients - a pilot study. Sleep Breath. 2012;16:773-739.
38. Chan AS, Lee RW, Cistulli PA. Dental appliance treatment for obstructive sleep apnea. Chest. 2007;132:693-699. (Pubitemid 47282408)
39. Kushida CA, Morgenthaler TI, Littner MR, et al. Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances: an update for 2005. Sleep. 2006;29:240-243. (Pubitemid 44019978)
40. Sundaram S, Bridgman SA, Lim J, et al. Surgery for obstructive sleep apnoea. Cochrane Database Syst Rev. 2005;(4):CD001004.
41. Caples SM, Rowley JA, Prinsell JR, et al. Surgical modifications of the upper airway for obstructive sleep apnea in adults: a systematic review and meta-analysis. Sleep. 2010;33:1396-1407.
42. Smith I, Lasserson TJ, Wright JJ. Drug therapy for obstructive sleep apnea in adults. Cochrane Database Syst Rev. 2006;():CD003002. Review.
43. Mason M, Welsh EJ, Smith I. Drug therapy for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2013;(5):CD003002.